Centinel focuses exclusively on treating cervical and lumbar spinal disease with its total disc replacement technology platform.
Prodisc cervical revenue reached $43 million, up 69% year over year. Prodisc lumbar revenue was also up 36% year over year.
Nearly 800 surgeons used Prodisc portfolio products in 2023, representing a 44% growth. 2023 also saw 250 new Prodisc users. Sales in ASCs also grew 56% year-over-year.
In 2023, Centinel launched the Prodisc C Vivo system and the Prodisc C SK, which saw nearly 3,700 procedures through the end of the year. The new systems drove a nearly 90% increase in full-year U.S. Prodisc cervical revenue and added an average of nearly 100 new surgeons per quarter.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
